FineTest
SKU(재고 관리 코드):FNab03469
anti- GJC2 antibody
anti- GJC2 antibody
Delve into the fascinating world of Gap Junction Protein Beta 2 (GJC2) and its roles in cell communication research with our Anti-GJC2 Antibody. Key features of this research tool include:
-
High Specificity: This antibody is expertly designed to specifically target GJC2, ensuring accuracy and reliability in your research. It recognizes GJC2 with remarkable specificity, facilitating precise data interpretation.
-
Cell Communication: Explore GJC2's involvement in gap junction formation, its potential implications in neurobiology and cell physiology studies, and its significance in understanding intercellular signaling.
-
Ideal Size: The 100µg size is perfect for multiple experiments while maintaining product freshness and quality.
-
Versatile Applications: This antibody is suitable for various research methodologies, whether you're studying neuronal communication, cell signaling, or GJC2's interactions with other cellular components.
Enhance your research in the fields of neuroscience, cell biology, and intercellular communication as you unravel the role of GJC2.
Product Name
GJC2 antibody
Size
100µg
Form
liquid
Purification
Immunogen affinity purified
Purity
≥95% as determined by SDS-PAGE
Host
Rabbit
Clonality
polyclonal
Isotype
IgG
Storage
PBS with 0.02% sodium azide and 50% glycerol pH 7.3, -20℃ for 12 months(Avoid repeated freeze / thaw cycles.)
BACKGROUND
One gap junction consists of a cluster of closely packed pairs of transmembrane channels, the connexons, through which materials of low MW diffuse from one cell to a neighboring cell. May play a role in myelination in central and peripheral nervous systems.
IMMUNOGEN INFORMATION
Immunogen
gap junction protein, gamma 2, 47kDa
Synonyms
GJA12
Observed MW
47 kDa
APPLICATION
Tested Application
ELISA, WB
Recommended Dilution
WB: 1:500-1:2000
UNIPROT INFORMATION
UniProt ID
IMAGES

mouse brain tissue were subjected to SDS PAGE followed by western blot with FNab03469( GJC2 Antibody) at dilution of 1:300
Share
